Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Yumanity Therapeutics

Yumanity Therapeutics
2014 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$31.1M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of innovative drugs intended to be used for the treatment of neurodegenerative diseases caused by protein misfolding. The company's innovative drugs specialize in the research and development of therapies for patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, enabling healthcare institutions to effectively cure neurodegenerative diseases and help patients lead a healthy life.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 790 Memorial Drive
  • Suite 2C
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Yumanity Therapeutics’s full profile, request a free trial.

Yumanity Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 29-Jun-2018 $31.1M 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Feb-2016 0000 0000 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Yumanity Therapeutics Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iconic Therapeutics Venture Capital-Backed South San Francisco, CA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Framingham, MA 0 0000 00000000
0000000 Venture Capital-Backed CA 000.00 00000000000 000.00
000000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Yumanity Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Biogen Corporation Minority 000 0000 000000 0
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0
Fidelity Management & Research Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Yumanity Therapeutics Executive Team (9)

Name Title Board
Seat
Contact
Info
N. Coles MD Co-Founder, Chairman and Chief Executive Officer
Kenneth Rhodes Ph.D Chief Scientific Officer
Paulash Mohsen Chief Business Officer
Vikram Khurana MD Senior Advisor, Discovery Technologies, Scientific Co-Founder
Daniel Tardiff Ph.D Associate Director, Yeast Phenotypic Screening & Scientific Co-Founder

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Yumanity Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Cecil Pickett Ph.D Self Board Member 000 0000
Jeffery Kelly Ph.D Self Board Member 000 0000
Joel Marcus JD Alexandria Venture Investments Board Member 000 0000
John Cox Self Board Member 000 0000
N. Coles MD Yumanity Therapeutics Co-Founder, Chairman and Chief Executive Officer 000 0000
You’re viewing 5 of 8 board members. Get the full list »